Dr
Oliver
Chammas

Patent Attorney

London Office

Life sciences

Telephone. +44(0) 207 776 5100
Email. [email protected]

Experience

Oliver is a chartered UK and European Patent Attorney who joined the London Office in September 2020. Oliver has a PhD in Bio-Nanotechnology and a degree in Medical Biochemistry from the University of Leeds. He has a wide range of experience in prosecution, contentious matters, drafting and freedom-to-operate.

Oliver has worked in private practice in IP for four years in both London and Yorkshire with a number of clients ranging from start-ups and universities to multinational companies.

Oliver's main area of focus is nanoscale biotechnology but he has also had experience with technologies such as biologics, medical devices, medical treatments, diagnostic and analytical methods, antibody technology and second medical use inventions for a range of diseases.

Oliver has experience of patent prosecution in the UK and Europe as well as advising clients as to patent prosecution in foreign jurisdictions including the United States, Japan and China.

Specialisms

  • Agbio
  • Bioprocessing
  • Cell and gene therapy
  • Diagnostics
  • Food technology
  • Gene editing technologies
  • Personalised medicine

Industries

  • Food & drink icon Food & drink
  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Patents
  • Portfolio management
  • Searching & competitor monitoring
  • Strategy
  • Transactional IP & commercial support

Qualifications

Patent Attorney

Chartered (UK)
European


BSC

Medical Biochemistry - University of Leeds

MSC

Integrated PhD & MSc – Molecular Scale Engineering – University of Leeds

PHD

Thesis entitled “Atomic Force Microscopy of DNA-protein Interactions” – University of Leeds

POSTGRADUATE DIPLOMA OR CERTIFICATE

Post-Graduate Certificate in Intellectual Property - Queen Mary University of London

Related News

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Getting your first filing right

One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …

Read article

Tarilian Laser Technologies - a case study in due diligence

When deciding whether to invest in a company, an investor will inevitably have to decide the value of the company. Taking a simplified view, a company’s valuation can be considered …

Read article

Health-conscious IP strategies

Strategies for navigating European patent portfolios in healthcare. Securing patent protection is critically important for innovative companies operating in the healthcare sector. European patent filings in healthcare, and particularly those …

Read article

Start-ups & IP, a case study: SleepCogni

Using SleepCogni as a case study, we look at some key ways that IP can help start-ups to develop their technology and secure investment. SleepCogni is a SleepTech start-up who …

Read article
Event - 9th December 2021

Technology Transfer Primer - IP Management: AI and 5G in healthcare

The University of Hong Kong is hosting a webinar on ‘IP Management: AI and 5G in healthcare’ on 9th December 2021 with HGF’s Partner Dr Chris Benson and Patent Director …

Event details
Event - 1st December 2021

Webinar: Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan

Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips …

Event details

Brand protection on e-commerce platforms

HGF recently presented on this topic at the Luxury Law Summit conference in London, which emphasised the need for brands to take a robust strategy to trade mark protection online. …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.